SurModics to Webcast Second Quarter 2015 Earnings Conference Call on April 30
Webcast is Live at 4:00 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 21, 2015--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its second
quarter 2015 conference call on Thursday, April 30, at 4:00 p.m. CT
(5:00 p.m. ET). The Company will issue an earnings news release after
the market closes that afternoon.
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance and chief financial officer, will recap the
second quarter 2015 financial results and accomplishments. To access the
webcast, go to the investor relations portion of the Company’s website
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on Thursday,
April 30, until 7:00 p.m. CT on Thursday, May 7, and can be accessed by
dialing 888-203-1112 and entering conference call ID passcode 8699575.
In addition, the conference call audio and transcript will be archived
on the Company’s website following the call.
About SurModics, Inc.
SurModics partners with the world's
leading and emerging medical device, diagnostic and life sciences
companies to develop and commercialize innovative products designed to
improve lives by enabling the detection and treatment of disease. Our
mission is to be a trusted partner to our customers by providing the
most advanced surface modification technologies and in vitro
diagnostic chemical components that help enhance the well-being of
patients. The company’s core offerings include surface modification
coating technologies that impart lubricity, prohealing and
biocompatibility characteristics and components for in vitro
diagnostic test kits and microarrays. SurModics is headquartered in Eden
Prairie, Minnesota. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
Andy LaFrence, 952-500-7000